In human gliomas, YAP suppresses glycogen synthase kinase 3 beta (GSK3β) activity, leading to increase the protein level and activity of β-catenin, which drives glioma cell proliferation (Wang et al., 2017). The gene discussed is GSK3B; the disease is central nervous system cancer.